0001437749-24-007350.txt : 20240311
0001437749-24-007350.hdr.sgml : 20240311
20240311180101
ACCESSION NUMBER: 0001437749-24-007350
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240307
FILED AS OF DATE: 20240311
DATE AS OF CHANGE: 20240311
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LEDOUX MARK A
CENTRAL INDEX KEY: 0001115556
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-15701
FILM NUMBER: 24739468
MAIL ADDRESS:
STREET 1: 1185 LINDA VISTA DR
CITY: SAN MARCOS
STATE: CA
ZIP: 92069
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NATURAL ALTERNATIVES INTERNATIONAL INC
CENTRAL INDEX KEY: 0000787253
STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 841007839
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: 1535 FARADAY AVENUE
CITY: CARLSBAD
STATE: CA
ZIP: 92008-7319
BUSINESS PHONE: 7607367700
MAIL ADDRESS:
STREET 1: 1535 FARADAY AVENUE
CITY: CARLSBAD
STATE: CA
ZIP: 92008-7319
FORMER COMPANY:
FORMER CONFORMED NAME: AMERICAN ACQUISITIONS INC
DATE OF NAME CHANGE: 19860929
4
1
rdgdoc.xml
FORM 4
X0508
4
2024-03-07
0000787253
NATURAL ALTERNATIVES INTERNATIONAL INC
NAII
0001115556
LEDOUX MARK A
1535 FARADAY AVENUE
CARLSBAD
CA
92008
1
1
1
CEO/Chairman
0
Common Stock
2024-03-07
4
F
0
5777
5.95
D
149121
D
Common Stock
2024-03-08
4
A
0
17000
0
A
166121
D
Common Stock
481905
I
By LeDoux Family Limited Partnership
Common Stock
69416
I
By IRA
Common Stock
7200
I
By Self as Custodian for Marcelle Jeannette LeDoux
Common Stock
800
I
By Self as Custodian for Jean-Marc Emile LeDoux
Common Stock
7500
I
By Self as Custodian for Aimee LeDoux
This transaction represents a resale of 5,777 shares to the Issuer as payment of the reporting person's tax liability upon vesting of 13,666 shares of restricted stock on March 7, 2024, using the closing stock price on March 7, 2024, of $5.95 per share.
This transaction represents a grant of restricted stock pursuant to the Issuer's 2020 Omnibus Incentive Plan.
One third (5,667 shares) of the restricted stock vests on March 7, 2025; one third (5,667 shares) of the restricted stock vests on March 7, 2026, and the final third (5,666 shares) of the restricted stock vests on March 7, 2027.
/s/ By Kenneth E. Wolf Attorney in Fact
2024-03-11